Review

hereditary cancer gene panel (Invitae Inc)

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Invitae Inc hereditary cancer gene panel
Hereditary Cancer Gene Panel, supplied by Invitae Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hereditary+cancers/cancers+common+hereditary+panel/pm41589608-61-1-8
Average 86 stars, based on 1 article reviews

hereditary cancer gene panel - by Bioz Stars, 2026-09

86/100 stars

Images

other:

Article Title: Differential Response to 177 Lu-PSMA-617 in Patients with Tumor Suppressor Gene-Mutated Metastatic Castration-Resistant Prostate Cancer.
Article Snippet: Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania; Division of Hematology/Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania; and Department of Radiology, Division of Nuclear Medicine Imaging and Therapy, University of Pennsylvania, Philadelphia, Pennsylvania

Article Title: Metastatic Cutaneous Adnexal Carcinoma of the Head and Neck With Durable Response to an Aromatase Inhibitor Combined With a Cyclin-Dependent Kinase 4/6 Inhibitor.
Article Snippet: A hereditary cancer gene panel was also negative (Invitae, San Francisco, CA).

Mutagenesis:

Article Title: Neoadjuvant Fc-enhanced anti-CTLA-4 targets Tregs to augment androgen deprivation in high-risk prostate cancer: A randomized phase I trial
Article Snippet: .. Baseline germline mutation testing was performed at trial screening using the Invitae Common Hereditary Cancers Panel (48 genes) or the Invitae Multi-Cancer Panel (70 genes). ..

Article Title: Neoadjuvant Fc-enhanced anti-CTLA-4 targets Tregs to augment androgen deprivation in high-risk prostate cancer: A randomized phase I trial.
Article Snippet: .. Baseline germline mutation testing was performed at trial screening using the Invitae Common Hereditary Cancers Panel (48 genes) or the Invitae Multi-Cancer Panel (70 genes). ..

Sequencing:

Article Title: Characteristics of Germline and Somatic Mutations of DNA Repair Genes in Korean Men with Prostate Cancer.
Article Snippet: .. The targeted cancer panel sequencing employed the Invitae Common Hereditary Cancer Panel (Invitae), Ion AmpliSeq Inherited Cancer Panel (Thermo Fisher Scientific), TruSight Oncology 500 assay (Illumina), and FoundationOne CDx (Foundation Medicine). ..

Article Title: Characteristics of Germline and Somatic Mutations of DNA Repair Genes in Korean Men with Prostate Cancer
Article Snippet: .. The targeted cancer panel sequencing employed the Invitae Common Hereditary Cancer Panel (Invitae), Ion AmpliSeq Inherited Cancer Panel (Thermo Fisher Scientific), TruSight Oncology 500 assay (Illumina), and FoundationOne CDx (Foundation Medicine). ..